Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Novozymes A/S
  6. Summary
    NZYM B   DK0060336014

NOVOZYMES A/S

(NZYM B)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Copenhagen
10/11/2021 10/12/2021 10/13/2021 10/14/2021 10/15/2021 Date
429.3(c) 432.4(c) 445(c) 440.3(c) 450.5(c) Last
207 110 147 788 288 886 239 703 307 973 Volume
-0.49% +0.72% +2.91% -1.06% +2.32% Change
More quotes
Estimated financial data (e)
Sales 2021 14 758 M 2 302 M 2 302 M
Net income 2021 3 084 M 481 M 481 M
Net Debt 2021 4 450 M 694 M 694 M
P/E ratio 2021 40,6x
Yield 2021 1,23%
Sales 2022 15 443 M 2 409 M 2 409 M
Net income 2022 3 151 M 491 M 491 M
Net Debt 2022 4 825 M 753 M 753 M
P/E ratio 2022 39,6x
Yield 2022 1,27%
Capitalization 125 B 19 450 M 19 459 M
EV / Sales 2021 8,75x
EV / Sales 2022 8,39x
Nbr of Employees 6 290
Free-Float 72,6%
More Financials
Company
Novozymes A/S is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - industry of cleaning and household maintenance products (34.8%); - food industry and human health (19.8%); - bioenergy (18%); - technical and cereal industries (14.3%): microorganisms used in the field of wastewater treatment, technical enzymes intended for the... 
Sector
Specialty Chemicals
Calendar
10/27Earnings Release
More about the company
Ratings of Novozymes A/S
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about NOVOZYMES A/S
10/14ANALYST RECOMMENDATIONS : Asos, Avis Budget, Meritage Homes, Kansas City Southern, UPS...
10/07NOVOZYMES A/S : and Anuvia Plant Nutrients to bring sustainable biobased nutrients to comm..
PU
09/29PRESS RELEASE : Mission 26: GEA presents growth strategy for the next five years
DJ
09/28GLOBAL MARKETS LIVE : Airbus, Merck, Geely, Toyota, Activision Blizzard...
09/28NOVOZYMES A/S : Expects To Double Revenue By 2030 Amid New Organic Growth Strategy
MT
09/27NOVOZYMES A/S : is unlocking growth with the ambition of doubling company revenue by 2030
GL
09/27NOVOZYMES ANNOUNCES ITS 2025 STRATEG : Unlocking growth – powered by biotech
AQ
09/24NOVOZYMES A/S : ' BioAg business strengthens its roots in the U.S.
PU
09/23NOVOZYMES A/S : named 2021 EPA Safer Choice Partner of the Year thanks to breakthroughs in..
PU
09/21NOVOZYMES A/S : Seeks Collaboration, Offers Partnership In Fungi-based Protein Sector
MT
09/21Novozymes is combining cutting-edge science and business expertise to help feed the wor..
GL
09/16PRESS RELEASE : GEA Group Aktiengesellschaft: Wins one of the largest orders in the compan..
DJ
09/15New enzyme expands the role of biological ingredients for laundry detergents
GL
08/30NOVOZYMES A/S : Transactions under Novozymes' stock buyback program
AQ
08/16RISING TO THE 1.5░C CHALLENGE : Fighting climate change with advanced biology
PU
More news
News in other languages on NOVOZYMES A/S
10/14MADRID STOCK EXCHANGE : LVMH, SAP y BlackRock hicieron el trabajo
10/14AVIS D'ANALYSTES DU JOUR : Air Liquide, Nestlé, EDF, ArcelorMittal, Arkema, CGG, Umicore, ..
10/14STOCK MARKET PARIS : LVMH, SAP et BlackRock ont fait le job
09/29Gea will Umsatz und Profitabilität deutlich steigern - Aktie gefragt
09/29MISSION 26 : GEA stellt Wachstumsstrategie für die nächsten fünf Jahre vor
More news
Analyst Recommendations on NOVOZYMES A/S
More recommendations
Chart NOVOZYMES A/S
Duration : Period :
Novozymes A/S Technical Analysis Chart | NZYM B | DK0060336014 | MarketScreener
Technical analysis trends NOVOZYMES A/S
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Last Close Price 450,50 DKK
Average target price 435,24 DKK
Spread / Average Target -3,39%
EPS Revisions
Managers and Directors
Ester Baiget President & Chief Executive Officer
Lars Green Chief Financial Officer & Executive Vice President
J°rgen Buhl Rasmussen Chairman
Claus Crone Fuglsang Chief Scientific Officer & Executive VP
Graziela Chaluppe dos Santos Malucelli Chief Operating Officer & Executive VP
Sector and Competitors